title: Hematologic Cancers Break Down a 'Checkpoint': Targeting the PD-1/PD-L1 Axis.
authors.forename: John
authors.initials: J
authors.lastname: Timmerman
mesh_terms: D000906:Antibodies / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008232:Lymphoproliferative Disorders / Q000188:drug therapy*; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors*
chemical_list: D000906:Antibodies; D000970:Antineoplastic Agents; D061026:Programmed Cell Death 1 Receptor